STAT3 cyclic oligonucleotide decoy-a new therapeutic avenue for NSCLC? [electronic resource]
Publication details: Translational lung cancer research Dec 2018Description: S381-S384 p. digitalISSN:- 2218-6751
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.